NO952483L - Seskviterpener, deres fremstilling og anvendelse som inhibitorer innvirkende på gababenzodiazepinreseptorer - Google Patents
Seskviterpener, deres fremstilling og anvendelse som inhibitorer innvirkende på gababenzodiazepinreseptorerInfo
- Publication number
- NO952483L NO952483L NO952483A NO952483A NO952483L NO 952483 L NO952483 L NO 952483L NO 952483 A NO952483 A NO 952483A NO 952483 A NO952483 A NO 952483A NO 952483 L NO952483 L NO 952483L
- Authority
- NO
- Norway
- Prior art keywords
- sesquiterpenes
- bond
- double bond
- gababenzodiazepine
- receptors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929226724A GB9226724D0 (en) | 1992-12-22 | 1992-12-22 | Pharmaceutical compounds |
| PCT/GB1993/002632 WO1994014814A1 (en) | 1992-12-22 | 1993-12-22 | Sesquiterpenes, their preparation and their use as inhibitors acting on the gaba-benzodiazepine receptor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO952483D0 NO952483D0 (no) | 1995-06-21 |
| NO952483L true NO952483L (no) | 1995-08-15 |
Family
ID=10727034
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO952483A NO952483L (no) | 1992-12-22 | 1995-06-21 | Seskviterpener, deres fremstilling og anvendelse som inhibitorer innvirkende på gababenzodiazepinreseptorer |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5565486A (fi) |
| EP (1) | EP0675888A1 (fi) |
| JP (1) | JPH08504804A (fi) |
| KR (1) | KR950704324A (fi) |
| AU (1) | AU677272B2 (fi) |
| BG (1) | BG99736A (fi) |
| BR (1) | BR9307712A (fi) |
| CA (1) | CA2151251A1 (fi) |
| CZ (1) | CZ284121B6 (fi) |
| FI (1) | FI953081A0 (fi) |
| GB (2) | GB9226724D0 (fi) |
| HU (1) | HUT71859A (fi) |
| IL (1) | IL108140A (fi) |
| MX (1) | MX9400174A (fi) |
| NO (1) | NO952483L (fi) |
| NZ (1) | NZ258986A (fi) |
| PL (1) | PL309628A1 (fi) |
| RU (1) | RU95113350A (fi) |
| SG (1) | SG67345A1 (fi) |
| SK (1) | SK77595A3 (fi) |
| TW (1) | TW242141B (fi) |
| WO (1) | WO1994014814A1 (fi) |
| ZA (1) | ZA939626B (fi) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070161095A1 (en) * | 2005-01-18 | 2007-07-12 | Gurin Michael H | Biomass Fuel Synthesis Methods for Increased Energy Efficiency |
| CA2797033C (en) | 2010-04-22 | 2021-10-19 | Longevity Biotech, Inc. | Highly active polypeptides and methods of making and using the same |
| US9789164B2 (en) | 2013-03-15 | 2017-10-17 | Longevity Biotech, Inc. | Peptides comprising non-natural amino acids and methods of making and using the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6348284A (ja) * | 1986-08-18 | 1988-02-29 | Yamanouchi Pharmaceut Co Ltd | 新抗生物質ｙｐ−０２９０８ｌ−ａおよびその製造法 |
| EP0301102B1 (en) * | 1987-02-06 | 1991-11-06 | Snow Brand Milk Products Co., Ltd. | NOVEL 7$g(b)-HYDROXY-4-PREGNENE-3,20-DIONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
| US5120723A (en) * | 1987-08-25 | 1992-06-09 | University Of Southern California | Method, compositions, and compounds for modulating brain excitability |
| JP2842613B2 (ja) * | 1989-04-28 | 1999-01-06 | 塩野義製薬株式会社 | フォスフォリパーゼａ▲下２▼阻害物質 |
| JPH03108490A (ja) * | 1989-06-30 | 1991-05-08 | Shionogi & Co Ltd | フォスフォリパーゼａ↓２阻害物質 |
| US5130430A (en) * | 1990-10-31 | 1992-07-14 | Neurogen Corporation | 2-substituted imidazoquinoxaline diones, a new class of gaba brain receptor ligands |
| US5189050A (en) * | 1991-06-03 | 1993-02-23 | Merck & Co., Inc. | Fermentation analogs of virginiamycin m1 to treat panic and anxiety disorder |
-
1992
- 1992-12-22 GB GB929226724A patent/GB9226724D0/en active Pending
-
1993
- 1993-12-22 SG SG1996008418A patent/SG67345A1/en unknown
- 1993-12-22 AU AU57096/94A patent/AU677272B2/en not_active Ceased
- 1993-12-22 EP EP94902938A patent/EP0675888A1/en not_active Ceased
- 1993-12-22 RU RU95113350/04A patent/RU95113350A/ru unknown
- 1993-12-22 BR BR9307712-2A patent/BR9307712A/pt not_active Application Discontinuation
- 1993-12-22 IL IL108140A patent/IL108140A/xx not_active IP Right Cessation
- 1993-12-22 HU HU9501840A patent/HUT71859A/hu unknown
- 1993-12-22 PL PL93309628A patent/PL309628A1/xx unknown
- 1993-12-22 ZA ZA939626A patent/ZA939626B/xx unknown
- 1993-12-22 GB GB9503413A patent/GB2284603B/en not_active Expired - Fee Related
- 1993-12-22 TW TW082110885A patent/TW242141B/zh active
- 1993-12-22 CZ CZ951646A patent/CZ284121B6/cs not_active IP Right Cessation
- 1993-12-22 CA CA002151251A patent/CA2151251A1/en not_active Abandoned
- 1993-12-22 JP JP6514956A patent/JPH08504804A/ja active Pending
- 1993-12-22 SK SK775-95A patent/SK77595A3/sk unknown
- 1993-12-22 NZ NZ258986A patent/NZ258986A/en unknown
- 1993-12-22 WO PCT/GB1993/002632 patent/WO1994014814A1/en active IP Right Grant
- 1993-12-22 KR KR1019950702562A patent/KR950704324A/ko not_active Application Discontinuation
- 1993-12-22 US US08/464,737 patent/US5565486A/en not_active Expired - Lifetime
-
1994
- 1994-01-03 MX MX9400174A patent/MX9400174A/es unknown
-
1995
- 1995-06-21 FI FI953081A patent/FI953081A0/fi not_active Application Discontinuation
- 1995-06-21 BG BG99736A patent/BG99736A/bg unknown
- 1995-06-21 NO NO952483A patent/NO952483L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB9503413D0 (en) | 1995-04-12 |
| CZ164695A3 (en) | 1995-11-15 |
| IL108140A (en) | 1997-06-10 |
| NZ258986A (en) | 1996-11-26 |
| GB2284603B (en) | 1996-03-27 |
| MX9400174A (es) | 1994-07-29 |
| AU5709694A (en) | 1994-07-19 |
| HUT71859A (en) | 1996-02-28 |
| TW242141B (fi) | 1995-03-01 |
| IL108140A0 (en) | 1994-04-12 |
| CZ284121B6 (cs) | 1998-08-12 |
| BR9307712A (pt) | 1999-08-31 |
| EP0675888A1 (en) | 1995-10-11 |
| BG99736A (bg) | 1996-04-30 |
| CA2151251A1 (en) | 1994-07-07 |
| HU9501840D0 (en) | 1995-08-28 |
| NO952483D0 (no) | 1995-06-21 |
| JPH08504804A (ja) | 1996-05-28 |
| KR950704324A (ko) | 1995-11-17 |
| FI953081A (fi) | 1995-06-21 |
| US5565486A (en) | 1996-10-15 |
| PL309628A1 (en) | 1995-10-30 |
| FI953081A0 (fi) | 1995-06-21 |
| GB2284603A (en) | 1995-06-14 |
| WO1994014814A1 (en) | 1994-07-07 |
| SG67345A1 (en) | 1999-09-21 |
| RU95113350A (ru) | 1997-06-10 |
| AU677272B2 (en) | 1997-04-17 |
| SK77595A3 (en) | 1995-12-06 |
| GB9226724D0 (en) | 1993-02-17 |
| ZA939626B (en) | 1994-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2130615A1 (en) | Methods of inhibiting vascular restenosis | |
| CA2054368A1 (en) | Azasteroid compounds for the treatment of prostatic hypertrophy, their preparation and use | |
| AU3155200A (en) | Cementing compositions and application of such compositions to cementing oil wells or the like | |
| MY118354A (en) | 1,3-propane diol derivatives as bioactive compounds | |
| CA2426632A1 (en) | Atorvastatin hemi-calcium form vii | |
| CA2124841A1 (en) | Swing phase control device | |
| AU6140696A (en) | Method of oil and gas transportation | |
| EP0227215A1 (en) | 1-Azatricycloalkylbenzamides, process for their preparation, and pharmaceutical compositions containing them | |
| Tanaka et al. | Structure of sporogen-AO 1, a sporogenic substance of Aspergillus oryzae | |
| NO952483L (no) | Seskviterpener, deres fremstilling og anvendelse som inhibitorer innvirkende på gababenzodiazepinreseptorer | |
| NO954761D0 (no) | Nye 1-fenylalkanoner som 5-HT4-reseptorligander | |
| EG20085A (en) | Process for preparing of imidazopyridine PAF/H2 antagonists | |
| CA2155323A1 (en) | Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof | |
| CA2043112A1 (en) | Foam-stabilized malt beverage | |
| AU9263298A (en) | Phospholipid analogue compounds | |
| KR930703312A (ko) | 아자비사이클로 [2.2.2]옥탄-3-이민의 제조방법 및 그의 제조용 중간체 | |
| JP3425763B2 (ja) | 有機化合物 | |
| Huffordx et al. | Metabolism of imipramine by microorganisms | |
| CA2126911A1 (en) | Isolation and structure of spongistatin 2, spongistatin 3, spongistatin 4 and spongistatin 6 | |
| WO2003010177B1 (en) | Novel penicillium isolates for modifying alternan | |
| Farooq et al. | Biotransformation of two cytotoxic terpenes, α-santonin and sclareol by Botrytis cinerea | |
| CA2067341A1 (en) | Method for synthesis of prostaglandin derivatives | |
| BG99545A (en) | Method for the preparation of dihydroartemisininsemisuccinate | |
| JPH0256443A (ja) | ストレプトミセス属の菌種からの新規なアングサイクリノンおよびその製法 | |
| AU7417000A (en) | Method of accumulating solar energy |